会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL PEPTIDES FOR HEPARIN ANTICOAGULATION REVERSAL
    • HEPARIN抗体逆转的新肽
    • WO1994004176A1
    • 1994-03-03
    • PCT/US1992006829
    • 1992-08-14
    • UNIVERSITY OF MICHIGANWAKEFIELD, Thomas, W.STANLEY, James, C.ANDREWS, Philip, C.
    • UNIVERSITY OF MICHIGAN
    • A61K37/02
    • C07K14/46A61K38/00C07K14/001
    • Less toxic agents for reversal of heparin anticoagulation which are synthetic protamine-like polycationic peptides having a total cationic charge which is less than that of n-protamine. In preferred embodiments, arginine residues of n-protamine are replaced with lysine residues for ease of manufacture. Selective positively charged arginine residues have been replaced with an uncharged amino acid residue or its analog, such as glycine or glutamine, in order to reduce the total cationic charge on the polycationic peptide to the range of about +14 to +18, preferably +16. In specific embodiments, there are sequences of 29 amino acid residues wherein 4 to 5 clusters of 2 to 4 positively charged amino acids are separated by 2 to 6 neutral amino acids.
    • 具有逆转肝素抗凝剂的毒性较小的药物,其是具有小于正精蛋白的总阳离子电荷的合成鱼精蛋白样聚阳离子肽。 在优选的实施方案中,为了易于制造,将n-鱼精蛋白的精氨酸残基替换为赖氨酸残基。 选择性带正电的精氨酸残基已被不带电荷的氨基酸残基或其类似物如甘氨酸或谷氨酰胺替代,以便将聚阳离子肽上的总阳离子电荷降低至约+14至+18,优选+16 。 在具体实施方案中,存在29个氨基酸残基的序列,其中2至4个带正电荷的氨基酸的4至5个簇被2至6个中性氨基酸分离。
    • 3. 发明申请
    • NOVEL PEPTIDES FOR HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ANTICOAGULATION REVERSAL
    • HEPARIN和低分子量HEPARIN抗体逆转的新肽
    • WO1996035444A1
    • 1996-11-14
    • PCT/US1996006567
    • 1996-05-08
    • UNIVERSITY OF MICHIGAN
    • UNIVERSITY OF MICHIGANWAKEFIELD, Thomas, W.STANLEY, James, C.ANDREWS, Philip, C.
    • A61K38/10
    • C07K14/001A61K38/00C07K14/46
    • Less toxic agents for reversal of heparin or low molecular weight heparin anticoagulation which are synthetic protamine-like polycationic peptides having a total cationic charge which is less than that of n-protamine. In preferred embodiments, arginine residues of n-protamine are replaced with lysine residues for ease of manufacture. Selective positively charged arginine residues have been replaced with an uncharged amino acid residue or its analog, such as glycine or glutamine, in order to reduce the total cationic charge on the polycationic peptide to the range of about [+14] to [+18], preferably [+16] to [+18]. In specific embodiments, there are sequences of 29 and 32 amino acid residues wherein 4 to 5 clusters of 2 to 4 positively charged amino acids are separated by 2 to 6 neutral amino acids. The C-terminus and the N-terminus can be modified to mitigate against in vivo degradation by carboxypeptidases and aminopeptidases. Another modification, specifically use of alpha -helix forming amino acids, such as glutamic acid, further promotes anticoagulation reversal. A still further modification includes the incorporation of a cell adhesion ligand, such as the RGD sequence, into the synthetic protamine-like polycationic peptide.
    • 具有逆转肝素或低分子量肝素抗凝剂的毒性较小的药物,其具有小于正精蛋白的总阳离子电荷的合成鱼精蛋白样聚阳离子肽。 在优选的实施方案中,为了易于制造,将n-鱼精蛋白的精氨酸残基替换为赖氨酸残基。 选择性带正电的精氨酸残基已被不带电荷的氨基酸残基或其类似物(如甘氨酸或谷氨酰胺)替代,以便将聚阳离子肽上的总阳离子电荷降低至约[+ 14]至[+ 18] ,优选[+ 16]至[+ 18]。 在具体实施方案中,存在29和32个氨基酸残基的序列,其中2至4个带正电荷的氨基酸的4至5个簇被2至6个中性氨基酸分开。 可以修饰C-末端和N-末端以减轻羧肽酶和氨基肽酶的体内降解。 另一个修改,特别是使用α-螺旋形成氨基酸,如谷氨酸,进一步促进抗凝反转。 另外的修饰包括将细胞粘附配体如RGD序列并入合成的鱼精蛋白样聚阳离子肽中。
    • 6. 发明申请
    • BIOANALYTICAL DETECTION SYSTEM
    • 生物检测系统
    • WO1991005262A1
    • 1991-04-18
    • PCT/US1990005511
    • 1990-09-27
    • UNIVERSITY OF MICHIGAN
    • UNIVERSITY OF MICHIGANSCHRAMM, Willfried
    • G01N33/543
    • G01N33/54366G01N33/743Y10S435/817Y10S436/806Y10S436/807
    • A device and process for detecting the presence of organic molecular analytes in a fluid comprising a first binding (18) component having a predetermined first affinity for specifically reversibly binding an analyte, a molecular conjugate of the analyte with a signal generating molecule that generates a detectable signal, and a second binding (20) component having a predetermined second affinity for reversibly binding the signal generating molecule. In the presence of analyte, a fluid conducting system allows competitive binding of the analyte with the molecular conjugate and causes displacement of the conjugate and conducts the displaced conjugate to the second binding component. The signal generating molecule generates a detectable signal distinguishing binding thereof at the first or second binding components thereby indicating the presence of the analyte in the fluid.
    • 一种用于检测流体中有机分子分析物的存在的装置和方法,包括具有预定的第一亲和力的第一结合(18)组分,用于特异性可逆地结合分析物,分析物的分子结合物与产生可检测的信号产生分子 信号,以及具有预定的第二亲和力的可逆结合信号产生分子的第二结合(20)组分。 在分析物的存在下,流体传导系统允许分析物与分子共轭物的竞争性结合并引起缀合物的位移并将置换的缀合物导向第二结合成分。 信号产生分子产生区分其在第一或第二结合组分上的结合的可检测信号,从而指示分析物在流体中的存在。
    • 7. 发明申请
    • MODE-LOCKED UPCONVERSION LASER SOURCE
    • 模式锁定的UPCONVERSION激光源
    • WO1994003948A1
    • 1994-02-17
    • PCT/US1993007355
    • 1993-08-05
    • UNIVERSITY OF MICHIGAN
    • UNIVERSITY OF MICHIGANRAND, Stephen, C.
    • H01S03/090
    • H01S3/094H01S3/081H01S3/094038H01S3/094092H01S3/1121H01S3/117H01S3/1608H01S3/165H01S3/1653
    • A laser source which operated under the principle of cooperative upconversion produces controllable optical pulses at wavelengths which are shorter than the wavelength of the laser energy which pumps the gain medium. The source is a solid-state laser which employs a five percent Er:LiYF crystal (Xtal) which is arranged in an astigmatically-compensated 3-mirror cavity (M1, M2, and M3). Pumping is achieved at 1.5 microns in the infrared, and the system operates in a continuous-wave, mode-lock fashion in the green spectral region at approximately 544 nm. The cooperative inversion mechanism involves energy pooling by trios of excited rare earth dopant ions in the laser medium. Q-switching is achieved with the use of intracavity amplitude modulation so as to achieve three-fold upconversion. A 3-mirror astigmatically-compensated cavity with the gain medium permits modulation of losses in a manner which cannot be achieved with known systems and achieves high stability.
    • 在协调上变频原理下运行的激光源产生的脉冲长度比泵浦增益介质的激光能量的波长短。 该源是使用布置在散光补偿的3镜腔(M1,M2和M3)中的5%Er:LiYF晶体(Xtal)的固态激光器。 在红外线中以1.5微米的速度实现泵送,并且系统以约544nm的绿色光谱区域中的连续波模式锁定方式工作。 合作反演机制涉及在激光介质中通过激发的稀土掺杂剂离子三元组的能量汇集。 通过使用腔内振幅调制实现Q开关,以实现三倍上变频。 具有增益介质的3镜式散光补偿腔允许以已知系统无法实现的方式调制损耗并实现高稳定性。